Gold nanoparticle-aided brachytherapy with vascular dose painting: Estimation of dose enhancement to the tumor endothelial cell nucleus

Medical Physics

Volumn 39, Issue 1, 2012, Pages 392-398

  Ngwa, Wilfred ^a   Makrigiorgos, G Mike ^a   Berbeco, Ross I ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

brachytherapy; dose enhancement; gold nanoparticles; vascular disrupting agents

Indexed keywords

CELL DEATH; ELECTRON ENERGY LEVELS; ENDOTHELIAL CELLS; ENERGY DISSIPATION; FIBER OPTIC SENSORS; IMAGE ENHANCEMENT; METAL NANOPARTICLES; ONCOLOGY; RADIOTHERAPY; TUMORS;

ANALYTIC CALCULATIONS; BRACHYTHERAPY; CONCENTRATION RANGES; DOSE ENHANCEMENT FACTORS; DOSE ENHANCEMENTS; ELECTRON ENERGY LOSS; VASCULAR DISRUPTING AGENTS; VASCULAR ENDOTHELIAL CELLS;

GOLD NANOPARTICLES;

EID: 84855453817     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3671905     Document Type: Article

References (55)

1. D. W. Siemann and M. R. Horsman, Targeting the tumor vasculature: A strategy to improve radiation therapy., Expert Rev. Anticancer Ther. 4, 321-327 (2004). 10.1586/14737140.4.2.321
2. D. W. Siemann and A. M. Rojiani, The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors., Int. J. Radiat. Oncol., Biol., Phys. 62, 846-853 (2005). 10.1016/j.ijrobp.2005.02.048
3. S. Boehm, C. Rothermundt, D. Hess, and M. Joerger, Antiangiogenic drugs in oncology: A focus on drug safety and the elderly-A mini-review., Gerontology 56, 303-309 (2010). 10.1159/000262450
4. M. R. Horsman and D. W. Siemann, Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies., Cancer Res. 66, 11520-11539 (2006). 10.1158/0008-5472.CAN-06-2848
5. M. R. Horsman and R. Murata, Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response., Int. J. Radiat. Oncol., Biol., Phys. 57, 1047-1055 (2003). 10.1016/S0360-3016(03)00769-7
6. D. J. Chaplin, G. R. Pettit, and S. A. Hill, Anti-vascular approaches to solid tumour therapy: Evaluation of combretastatin A4 phosphate., Anticancer Res. 19, 189-195 (1999).
7. M. R. Horsman, A. B. Bohn, and M. Busk, Vascular targeting therapy: Potential benefit depends on tumor and host related effects., Exp. Oncol. 32, 143-148 (2010).
8. G. M. Tozer, C. Kanthou, G. Lewis, V. E. Prise, B. Vojnovic, and S. A. Hill, Tumour vascular disrupting agents: Combating treatment resistance., Br. J. Radiol. 81 (Spec No 1), S12-S20 (2008). 10.1259/bjr/36205483
9. W. R. Wilson, A. E. Li, D. S. Cowan, and B. G. Siim, Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid., Int. J. Radiat. Oncol., Biol., Phys. 42, 905-908 (1998). 10.1016/S0360-3016(98)00358-7
10. L. Li, A. Rojiani, and D. W. Siemann, Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: Effects on radiation therapy., Int. J. Radiat. Oncol., Biol., Phys. 42, 899-903 (1998). 10.1016/S0360-3016(98)00320- 4
11. D. W. Siemann, The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents., Cancer Treat. Rev. 37, 63-74 (2011). 10.1016/j.ctrv.2010.05.001
12. C. Lasagna-Reeves, D. Gonzalez-Romero, M. A. Barria, I. Olmedo, A. Clos, V. M. Sadagopa Ramanujam, A. Urayama, L. Vergara, M. J. Kogan, and C. Soto, Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice., Biochem. Biophys. Res. Commun. 393, 649-655 (2010). 10.1016/j.bbrc.2010.02.046
13. W. Ngwa, G. M. Makrigiorgos, and R. I. Berbeco, Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: Estimation of endothelial dose enhancement., Phys. Med. Biol. 55, 6533-6548 (2010). 10.1088/0031-9155/55/21/013
14. R. I. Berbeco, W. Ngwa, and G. M. Makrigiorgos, Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage x-rays and targeted gold nanoparticles: New potential for external beam radiotherapy., Int. J. Radiation Oncology Biol. Phys.81, 270-276 (2011). 10.1016/j.ijrobp.2010.10. 022
15. M. Garcia-Barros, F. Paris, C. Cordon-Cardo, D. Lyden, S. Rafii, A. Haimovitz-Friedman, Z. Fuks, and R. Kolesnick, Tumor response to radiotherapy regulated by endothelial cell apoptosis., Science 300, 1155-1159 (2003). 10.1126/science.1082504
16. Z. Fuks and R. Kolesnick, Engaging the vascular component of the tumor response., Cancer Cell 8, 89-91 (2005). 10.1016/j.ccr.2005.07.014
17. T. R. Munro, The relative radiosensitivity of the nucleus and cytoplasm of Chinese hamster fibroblasts., Radiat. Res. 42, 451-470 (1970). 10.2307/3572962
18. A. I. Amin, R. W. Howell, K. S. R. Sastry, and S. J. Adelstein, Positional Effects of Auger Degays in Mammalian Cells in Culture (Taylor Francis, London, 1988).
19. S. H. Cho, B. L. Jones, and S. Krishnan, The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources., Phys. Med. Biol. 54, 4889-4905 (2009). 10.1088/0031-9155/54/16/004
20. F. Van den Heuvel, J. P. Locquet, and S. Nuyts, Beam energy considerations for gold nano-particle enhanced radiation treatment., Phys. Med. Biol. 55, 4509-4520 (2010). 10.1088/0031-9155/55/16/S06
21. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter, Molecular Biology of the Cell, 4th ed. (Garland Science, New York, 2002).
22. A. Vaziri and M. R. Mofrad, Mechanics and deformation of the nucleus in micropipette aspiration experiment., J. Biomech. 40, 2053-2062 (2007). 10.1016/j.jbiomech.2006.09.023
23. O. Cohen-Fix, Cell biology: Import and nuclear size., Nature (London) 468, 513-516 (2010). 10.1038/468513a
24. E. Lechtman, N. Chattopadhyay, Z. Cai, S. Mashouf, R. Reilly, and J. P. Pignol, Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location., Phys. Med. Biol. 56, 4631-4647 (2011). 10.1088/0031-9155/56/15/ 001
25. H. F. Dvorak, J. A. Nagy, J. T. Dvorak, and A. M. Dvorak, Identification and characterization of the blood-vessels of solid tumors that are leaky to circulating macromolecules., Am. J. Pathol. 133, 95-109 (1988).
26. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review., J. Controlled Release 65, 271-284 (2000). 10.1016/S0168-3659(99)00248-5
27. L. Brannon-Peppas and J. O. Blanchette, Nanoparticle and targeted systems for cancer therapy., Adv. Drug Delivery Rev. 56, 1649-1659 (2004). 10.1016/j.addr.2004.02.014
28. S. D. Perrault, C. Walkey, T. Jennings, H. C. Fischer, and W. C. W. Chan, Mediating tumor targeting efficiency of nanoparticles through design., Nano Lett. 9, 1909-1915 (2009). 10.1021/nl900031y
29. A. Cole, Absorption of 20-eV to 50,000-eV electron beams in air and plastic., Radiat. Res. 38, 7-33 (1969). 10.2307/3572707
30. G. M. Makrigiorgos, S. J. Adelstein, and A. I. Kassis, Cellular radiation dosimetry and its implications for estimation of radiation risks. Illustrative results with technetium 99m-labeled microspheres and macroaggregates., Jama 264, 592-595 (1990). 10.1001/jama.1990.03450050050026
31. G. M. Makrigiorgos, S. Ito, J. Baranowska-Kortylewicz, D. W. Vinter, A. Iqbal, A. D. Van den Abbeele, S. J. Adelstein, and A. I. Kassis, Inhomogeneous deposition of radiopharmaceuticals at the cellular level: Experimental evidence and dosimetric implications., J. Nucl. Med. 31, 1358-1363 (1990).
32. J. F. Hainfeld, F. A. Dilmanian, Z. Zhong, D. N. Slatkin, J. A. Kalef-Ezra, and H. M. Smilowitz, Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma., Phys. Med. Biol. 55, 3045-3059 (2010). 10.1088/0031-9155/55/11/004
33. J. F. Hainfeld, D. N. Slatkin, and H. M. Smilowitz, The use of gold nanoparticles to enhance radiotherapy in mice., Phys. Med. Biol. 49, N309-N315 (2004). 10.1088/0031-9155/49/18/N03
34. K. Sokolov, M. Follen, J. Aaron, I. Pavlova, A. Malpica, R. Lotan, and R. Richards-Kortum, Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles., Cancer Res. 63, 1999-2004 (2003).
35. C. H. Choi, C. A. Alabi, P. Webster, and M. E. Davis, Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles., Proc. Natl. Acad. Sci. U.S.A. 107, 1235-1240 (2010). 10.1073/pnas.0914140107
36. S. D. Brown, P. Nativo, J. Smith, D. Stirling, P. R. Edwards, B. Venugopal, D. J. Flint, J. A. Plumb, D. Graham, and N. J. Wheate, Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin., J. Am. Chem. Soc. 132, 4678-4684 (2010). 10.1021/ja908117a
37. S. Dabbas, R. R. Kaushik, S. Dandamudi, M. Kuesters, and R. B. Campbell, Importance of the liposomal cationic lipid content and type in tumor vascular targeting: Physicochemical characterization and in vitro studies using human primary and transformed endothelial cells., Endothelium 15, 189-201 (2008). 10.1080/10623320802228583
38. W. Cai, D. W. Shin, K. Chen, O. Gheysens, Q. Cao, S. X. Wang, S. S. Gambhir, and X. Chen, Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects., Nano Lett. 6, 669-676 (2006). 10.1021/nl052405t
39. P. Diagaradjane, J. M. Orenstein-Cardona, N. E. Colon-Casasnovas, A. Deorukhkar, S. Shentu, N. Kuno, D. L. Schwartz, J. G. Gelovani, and S. Krishnan, Imaging epidermal growth factor receptor expression in vivo: Pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe., Clin. Cancer Res. 14, 731-741 (2008). 10.1158/1078-0432.CCR-07-1958
40. J. R. McCarthy and R. Weissleder, Multifunctional magnetic nanoparticles for targeted imaging and therapy., Adv. Drug Delivery Rev. 60, 1241-1251 (2008). 10.1016/j.addr.2008.03.014
41. X. Qian, X. H. Peng, D. O. Ansari, Q. Yin-Goen, G. Z. Chen, D. M. Shin, L. Yang, A. N. Young, M. D. Wang, and S. Nie, In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags., Nat. Biotechnol. 26, 83-90 (2008). 10.1038/nbt1377
42. S. H. Cho, Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: A preliminary Monte Carlo study., Phys. Med. Biol. 50, N163-N173 (2005). 10.1088/0031-9155/50/15/N01
43. E. Ryschich, E. Schmidt, S. M. Maksan, E. Klar, and J. Schmidt, Expansion of endothelial surface by an increase of vessel diameter during tumor angiogenesis in experimental and hepatocellular and pancreatic cancer., World J. Gastroenterol. 10, 3171-3174 (2004).
44. R. Weissleder, K. Kelly, E. Y. Sun, T. Shtatland, and L. Josephson, Cell-specific targeting of nanoparticles by multivalent attachment of small molecules., Nat. Biotechnol. 23, 1418-1423 (2005). 10.1038/nbt1159
45. B. Kang, M. A. Mackey, and M. A. El-Sayed, Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis., J. Am. Chem. Soc. 132, 1517-1519 (2010). 10.1021/ja9102698
46. P. Mukherjee, R. Bhattacharya, P. Wang, L. Wang, S. Basu, J. A. Nagy, A. Atala, D. Mukhopadhyay, and S. Soker, Antiangiogenic properties of gold nanoparticles., Clin. Cancer Res. 11, 3530-3534 (2005). 10.1158/1078-0432.CCR- 04-2482
47. R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R. R. Bhonde, and M. Sastry, Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview., Langmuir 21, 10644-10654 (2005). 10.1021/la0513712
48. E. E. Connor, J. Mwamuka, A. Gole, C. J. Murphy, and M. D. Wyatt, Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity., Small 1, 325-327 (2005). 10.1002/smll.v1:3
49. J. F. Hainfeld, D. N. Slatkin, T. M. Focella, and H. M. Smilowitz, Gold nanoparticles: A new x-ray contrast agent., Br. J. Radiol. 79, 248-253 (2006). 10.1259/bjr/13169882
50. H. Korideck, W. Ngwa, G. M. Makrigiorgos, and R. I. Berbeco, The quantification of gold nanoparticles as contrast agents for small animal volumetric studies., Int. J. Radiation Oncology Biol. Phys. 81, S887-S888 (2011). 10.1016/j.ijrobp.2011.06.1588
51. R. P. Mason, D. Zhao, L. Liu, M. L. Trawick, and K. G. Pinney, A perspective on vascular disrupting agents that interact with tubulin: Preclinical tumor imaging and biological assessment., Integr. Biol. 3, 375-387 (2011). 10.1039/c0ib00135j
52. M. C. Daniel and D. Astruc, Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology., Chem. Rev. 104, 293-346 (2004). 10.1021/cr030698+
53. G. S. Terentyuk, G. N. Maslyakova, L. V. Suleymanova, N. G. Khlebtsov, B. N. Khlebtsov, G. G. Akchurin, I. L. Maksimova, and V. V. Tuchin, Laser-induced tissue hyperthermia mediated by gold nanoparticles: Toward cancer phototherapy., J. Biomed. Opt. 14, 021016 (2009). 10.1117/1.3122371
54. K. M. Farjo and J. X. Ma, The potential of nanomedicine therapies to treat neovascular disease in the retina., J. Angiogenesis Res. 2, 21 (2010). 10.1186/2040-2384-2-21
55. R. R. Arvizo, S. Rana, O. R. Miranda, R. Bhattacharya, V. M. Rotello, and P. Mukherjee, Mechanism of anti-angiogenic property of gold nanoparticles: Role of nanoparticle size and surface charge., Nanomedicine: Nanotechnol. Biol. Med. 7, 580-587 (2011). 10.1016/j.nano.2011.01.011